表紙
市場調查報告書

全球核酸適體市場 - 成長,趨勢,及預測(2019年 - 2024年)

Aptamers Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品編碼 391436
出版日期 內容資訊 英文 110 Pages
商品交期: 2-3個工作天內
價格
Back to Top
全球核酸適體市場 - 成長,趨勢,及預測(2019年 - 2024年) Aptamers Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年03月01日內容資訊: 英文 110 Pages
簡介

全球核酸適體市場在2019年∼2024年間,預測將以17.8%的年複合成長率成長。核酸適體開發技術的進步,研究開發費的增加,該市場的投資企業增加等,是支撐這個市場成長的重要要素。

本報告提供全球核酸適體市場的相關調查,市場機會及趨勢,成長及阻礙因素,各類型、用途、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 研究的成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
  • 市場阻礙因素
  • 波特的五力分析
    • 新加入廠商的威脅
    • 買主/消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 產業內的競爭

第5章 市場區隔

  • 各類型
    • 核酸
  • 各用途
    • 診斷
    • 治療學
    • 研究開發
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東及非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • AM Biotechnologies, LLC
    • Aptagen, LLC
    • Aptamer Sciences, Inc.
    • Aptamer Group
    • Aptus Biotech S.L.
    • Base Pair Biotechnologies, Inc.
    • NOXXON Pharma
    • SomaLogic Inc.
    • TriLink BioTechnologies, Inc.
    • Vivonics, Inc.

第7章 市場機會及未來趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 46393

Market Overview

The global aptamers market is expected to witness a CAGR of 17.8% during the forecast period. Advancements in aptamer development technologies, increasing R&D expenditure, and the rising number of companies investing in this market are some of the key driving factors responsible for the growth of this market. Numerous advantages offered by these small molecules, in comparison to established antibodies, have also led to higher demand for these molecules across a diverse range of medical applications. They are chemically synthesized, which eliminates batch-to-batch variation and demands less time for development. Along with this, continuous advancement in technologies is expected to stimulate growth.

However, many aptamers have failed to meet the requisite safety and efficacy standards in clinical studies. Thus, companies have to terminate their clinical investigation during late-stage clinical studies. This factor is likely to affect the growth of this market negatively. In addition, other factors, such as low awareness about these technologies in middle- and low-income countries and inadequate regulatory structure, may hamper the overall growth.

Scope of the Report

Aptamers are short, single-stranded DNA or RNA (ssDNA or ssRNA) molecules, which can selectively bind to a specific target, including peptides, proteins, small molecules, carbohydrates, toxins, and even live cells. Aptamers assume various shapes, owing to their tendency to form helices or single-stranded loops. These molecules are extremely versatile and are used to bind targets with high specificity and selectivity.

Key Market Trends

Diagnostics is expected to hold a Significant Market Share in the Application Type Segmentation

Appropriate diagnosis is the most crucial factor for the treatment of diseases, especially the viral ones. Over the past few years, aptamer technology has observed a significant rise in its demand and usage all across the world. It has been used in a wide range of diagnostic as well as therapeutic applications; several strategies are currently being explored, in a definitive or conclusive way, using aptamers against virus proteins. From a diagnostic point of view, aptamers are presently being designed as a bio-recognition element in a variety of diagnostic systems in order to detect viral proteins, either in the blood (serum or plasma) or in the infected cells.

North America dominates the Market and expected to do the Same in the Forecast Period

By geography, the aptamers market is segmented into North America, Europe, Asia-Pacific, the Middle East & Africa, and South America. North America dominates the aptamers market due to rapid technological advancements and high investment and funding to support the development of aptamers. Asia-Pacific is also expected to propel the global aptamers market, owing to factors, such as increasing research & development activities and economic growth.

Competitive Landscape

The global aptamers market is highly competitive and consists of a number of major players. Companies, like AM Biotechnologies, LLC, Aptagen, LLC, Aptamer Sciences, Inc., Aptamer Group, Aptus Biotech S.L., Base Pair Biotechnologies, Inc., NOXXON Pharma, SomaLogic Inc., TriLink BioTechnologies, Inc., and Vivonics, Inc., among others, hold the substantial share in the aptamers market.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 High Advantage of Aptamers Compared to Antibodies
    • 4.2.2 Advancements in the Field of Aptamer Development Technologies
    • 4.2.3 Growing Investment by Major Companies
  • 4.3 Market Restraints
    • 4.3.1 Rising Number of Setbacks of Aptamer Therapeutics in Late Stage Clinical Studies
    • 4.3.2 Low Awareness Level and Incomplete Regulatory Policies
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 Type
    • 5.1.1 Nucleic Acid
    • 5.1.2 Peptide
  • 5.2 Application
    • 5.2.1 Diagnostics
    • 5.2.2 Therapeutics
    • 5.2.3 Research and Development
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 US
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 UK
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East & Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East & Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 AM Biotechnologies, LLC
    • 6.1.2 Aptagen, LLC
    • 6.1.3 Aptamer Sciences, Inc.
    • 6.1.4 Aptamer Group
    • 6.1.5 Aptus Biotech S.L.
    • 6.1.6 Base Pair Biotechnologies, Inc.
    • 6.1.7 NOXXON Pharma
    • 6.1.8 SomaLogic Inc.
    • 6.1.9 TriLink BioTechnologies, Inc.
    • 6.1.10 Vivonics, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top